JB

Jamil Beg

Venture Capitalist & Bioentrepreneur

Cambridge, Massachusetts

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Partner

    2024

  • Founding Investor

    2020

    Clinical stage, small molecule company developing inhaled therapeutics for respiratory diseases

  • Board of Directors

    2020

  • Founding Investor

    2022

    Stealth stage genetic renal disease company

  • Chief Executive Officer

    2022 - 2023

  • Founder

    2018

    Clinical stage, precision neuroscience company developing small molecules to transform the lives of patients suffering from neurological diseases

  • Board of Directors

    2018 - 2023

  • Chief Executive Officer

    2018 - 2021

2017 - 2023

  • Partner

    2017 - 2023

    5AM Ventures is an early stage life science venture fund focused on company creation and investments in seed and Series A companies

2019 - 2022

  • Guest Lecturer

    2019 - 2022

2018 - 2021

  • Board Observer

    2018 - 2021

    Clinical stage company developing transformative breakthrough therapies for patients with severe and rare disorders (IPO in July 2021)

2007 - 2021

  • Board Member

    2007 - 2021

2017 - 2021

  • Mentor

    2017 - 2021

2017 - 2020

  • Board Observer

    2017 - 2020

    Clinical stage, gene therapy company developing treatments for inner ear disorders (IPO in June 2020; acquired by Eli Lilly in October 2022)